Comerica Bank Macrogenics Inc Transaction History

Comerica Bank

$24.4 Billion
Q4 2024

A detailed history of Comerica Bank transactions in Macrogenics Inc stock. As of the latest transaction made, Comerica Bank holds 44 shares of MGNX stock, worth $112. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$112

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$3.18 - $4.46 $139 - $196	44 New	44 $0
Q1 2024 May 15, 2024	BUY	$9.77 - $21.47 $429 - $944	44 New	44 $0

Others Institutions Holding MGNX

# of Institutions

130

Shares Held

55.3M

Call Options Held

87.3K

Put Options Held

228K

Bellevue Group Ag Kuesnacht, V8

9.93M
Shares

$25.4 Million
0.64% of portfolio
Armistice Capital, LLC New York, NY

6.28M
Shares

$16.1 Million
0.29% of portfolio
Black Rock Inc. New York, NY

5.4M
Shares

$13.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.32M
Shares

$11.1 Million
0.0% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.49M
Shares

$8.93 Million
0.06% of portfolio

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $157M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account